Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 31,738 | 114,109 | 9,698 | 8,466 | 7,470 |
| Gross Profit | 31,738 | 114,109 | 9,698 | 8,466 | 7,470 |
| Operating Expenses | 138,953 | 131,554 | 136,509 | 128,617 | 126,756 |
| Operating Income | -107,215 | -17,445 | -126,811 | -120,151 | -119,286 |
| Other Income | 12,897 | 260,802 | 14,083 | 17,860 | 10,956 |
| Pre-tax Income | -94,318 | 243,357 | -112,728 | -102,291 | -108,330 |
| Net Income Continuous | -94,318 | 243,357 | -112,728 | -102,291 | -108,330 |
| Net Income | $-94,318 | $243,357 | $-112,728 | $-102,291 | $-108,330 |
| EPS Basic Total Ops | -0.91 | 2.52 | -1.10 | -1.00 | -1.23 |
| EPS Basic Continuous Ops | -0.91 | 2.52 | -1.10 | -1.00 | -1.23 |
| EPS Diluted Total Ops | -0.91 | 2.52 | -1.10 | -1.00 | -1.23 |
| EPS Diluted Continuous Ops | -0.91 | 2.52 | -1.10 | -1.00 | -1.23 |
| EPS Diluted Before Non-Recurring Items | -0.91 | -0.10 | -1.10 | -1.00 | -1.24 |
| EBITDA(a) | $-104,338 | $-15,035 | $-125,484 | $-119,231 | $-117,607 |